![](/img/cover-not-exists.png)
Pembrolizumab in Combination with Ipilimumab as Second-Line or Later Therapy for Advanced Non–Small-Cell Lung Cancer: KEYNOTE-021 Cohorts D and H
Gubens, M.A., Sequist, L.V., Stevenson, J.P., Powell, S.F., Villaruz, L.C., Gadgeel, S.M., Langer, C.J., Patnaik, A., Borghaei, H., Jalal, S.I., Fiore, J., Saraf, S., Raftopoulos, H., Gandhi, L.Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2018.12.015
Date:
December, 2018
File:
PDF, 494 KB
english, 2018